Retreatment with 90Y-labelled ibritumomab tiuxetan in a patient with follicular lymphoma who had previously responded to treatment.
Peyrade
Frederic
F
Department of Medical Oncology, Antoine-Lacassagne Centre, Nice, France.
Italiano
Antoine
A
Fontana
Xavier
X
Peyrottes
Isabelle
I
Thyss
Antoine
A
D000368:Aged; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D006801:Humans; D008224:Lymphoma, Follicular / Q000532:radiotherapy*; D008297:Male; D009364:Neoplasm Recurrence, Local / Q000532:radiotherapy; D016499:Radioimmunotherapy; D019233:Retreatment; D015021:Yttrium Radioisotopes / Q000627:therapeutic use
D000911:Antibodies, Monoclonal; D015021:Yttrium Radioisotopes; C422802:ibritumomab tiuxetan